6CM
ISEE

683 Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

683 Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-33,608
Closed -$288K – 186
2019
Q4 		$288K Buy
+33,608
New +$120K 0.03% 90
2017
Q1 		– Sell
-100,000
Closed -$483K – 115
2016
Q4 		$483K Buy
+100,000
New +$2.97M 0.03% 98

Other funds holding ISEE

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BCM
Burrage Capital Management Boston, Massachusetts $99.7M AUM 66.05% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

683 Capital Management's ISEE Position: Q1 2020 in Review

683 Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2020, closing a stake of 33,608 shares — an estimated $288K sold.

683 Capital Management first reported a position in ISEE in Q4 2016 and held it in 2 quarters. The position peaked at $483K in Q4 2016. 75 funds tracked by Wall St. Rank hold ISEE as of Q1 2020.

  • 683 Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • 683 Capital Management sold 33,608 IVERIC bio, Inc. Common Stock shares in Q1 2020, an estimated $288K.
  • 683 Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 2 quarters.
  • 683 Capital Management's IVERIC bio, Inc. Common Stock position peaked at $483K in Q4 2016.
  • 75 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2020.

Based on 683 Capital Management's 13F filing for Q1 2020, filed 15 May 2020.